{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:50:26Z","timestamp":1793260226832,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11883-019-0790-x","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T10:52:17Z","timestamp":1558435937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Anticoagulation Resumption After Stroke from Atrial Fibrillation"],"prefix":"10.1007","volume":"21","author":[{"given":"Brian","family":"Mac Grory","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Flood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Schrag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Paciaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Yaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,20]]},"reference":[{"issue":"10","key":"790_CR1","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1212\/WNL.28.10.973","volume":"28","author":"PA Wolf","year":"1978","unstructured":"Wolf PA, Dawber TR, Thomas HE, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology. 1978;28(10):973\u20137.","journal-title":"Neurology."},{"issue":"6","key":"790_CR2","first-page":"937","volume":"19","author":"X Li","year":"2017","unstructured":"Li X, Tse VC, Au-Doung LW, Wong ICK, Chan EW. The impact of ischaemic stroke on atrial fibrillation-related healthcare cost: a systematic review. Europace. 2017;19(6):937\u201347.","journal-title":"Europace."},{"issue":"5","key":"790_CR3","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011112","volume":"8","author":"HF Lee","year":"2019","unstructured":"Lee HF, Chan YH, Chang SH, Tu HT, Chen SW, Yeh YH, et al. Effectiveness and safety of non-vitamin K antagonist oral anticoagulant and warfarin in cirrhotic patients with nonvalvular atrial fibrillation. J Am Heart Assoc. 2019;8(5):e011112.","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"790_CR4","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857\u201367.","journal-title":"Ann Intern Med"},{"issue":"8","key":"790_CR5","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1161\/STROKEAHA.107.510321","volume":"39","author":"M Paciaroni","year":"2008","unstructured":"Paciaroni M, Agnelli G, Corea F, Ageno W, Alberti A, Lanari A, et al. Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke. 2008;39(8):2249\u201356.","journal-title":"Stroke."},{"issue":"5","key":"790_CR6","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00415-014-7297-8","volume":"261","author":"S Tan","year":"2014","unstructured":"Tan S, Wang D, Liu M, Zhang S, Wu B, Liu B. Frequency and predictors of spontaneous hemorrhagic transformation in ischemic stroke and its association with prognosis. J Neurol. 2014;261(5):905\u201312.","journal-title":"J Neurol"},{"issue":"1","key":"790_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/neurintsurg-2013-010743","volume":"7","author":"RG Nogueira","year":"2015","unstructured":"Nogueira RG, Gupta R, Jovin TG, Levy EI, Liebeskind DS, Zaidat OO, et al. Predictors and clinical relevance of hemorrhagic transformation after endovascular therapy for anterior circulation large vessel occlusion strokes: a multicenter retrospective analysis of 1122 patients. J Neurointerv Surg. 2015;7(1):16\u201321.","journal-title":"J Neurointerv Surg"},{"issue":"7","key":"790_CR8","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","volume":"45","author":"WN Kernan","year":"2014","unstructured":"Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2014;45(7):2160\u2013236.","journal-title":"Stroke."},{"issue":"3","key":"790_CR9","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","volume":"49","author":"WJ Powers","year":"2018","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2018;49(3):e46\u2013e110.","journal-title":"Stroke."},{"issue":"10","key":"790_CR10","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/europace\/euv309","volume":"17","author":"H Heidbuchel","year":"2015","unstructured":"Heidbuchel H, Verhamme P, Alings M, Antz M, Diener HC, Hacke W, et al. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace. 2015;17(10):1467\u2013507.","journal-title":"Europace."},{"issue":"3","key":"790_CR11","first-page":"e28","volume":"129","author":"AS Go","year":"2014","unstructured":"Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics\u20142014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28\u2013e292.","journal-title":"Circulation."},{"issue":"4","key":"790_CR12","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1161\/STROKEAHA.117.020031","volume":"49","author":"R Ornello","year":"2018","unstructured":"Ornello R, Degan D, Tiseo C, Di Carmine C, Perciballi L, Pistoia F, et al. Distribution and temporal trends from 1993 to 2015 of ischemic stroke subtypes: a systematic review and meta-analysis. Stroke. 2018;49(4):814\u20139.","journal-title":"Stroke."},{"issue":"1","key":"790_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/STROKEAHA.118.022249","volume":"50","author":"Gabriel S.C. Yiin","year":"2019","unstructured":"Yiin GSC, Li L, Bejot Y, Rothwell PM. Time trends in atrial fibrillation-associated stroke and premorbid anticoagulation population-based study and systematic review. Stroke. 2019;50:21\u201327. \n                      https:\/\/doi.org\/10.1161\/STROKEAHA.118.022249","journal-title":"Stroke"},{"issue":"2","key":"790_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263\u201372.","journal-title":"Chest."},{"issue":"8","key":"790_CR15","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1161\/STROKEAHA.115.008891","volume":"46","author":"M Paciaroni","year":"2015","unstructured":"Paciaroni M, Agnelli G, Falocci N, Caso V, Becattini C, Marcheselli S, et al. Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: effect of anticoagulation and its timing: the RAF study. Stroke. 2015;46(8):2175\u201382.","journal-title":"Stroke."},{"issue":"2","key":"790_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00415-015-7957-3","volume":"263","author":"M Paciaroni","year":"2016","unstructured":"Paciaroni M, Agnelli G, Falocci N, Caso V, Becattini C, Marcheselli S, et al. Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study. J Neurol. 2016;263(2):231\u20137.","journal-title":"J Neurol"},{"issue":"5","key":"790_CR17","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1161\/01.STR.14.5.688","volume":"14","author":"RG Hart","year":"1983","unstructured":"Hart RG, Coull BM, Hart D. Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study. Stroke. 1983;14(5):688\u201393.","journal-title":"Stroke."},{"issue":"10","key":"790_CR18","first-page":"1760","volume":"27","author":"HJ Lin","year":"1996","unstructured":"Lin HJ, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, et al. Stroke severity in atrial fibrillation. The Framingham Study. s. 1996;27(10):1760\u20134.","journal-title":"s"},{"issue":"10","key":"790_CR19","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1161\/01.STR.27.10.1765","volume":"27","author":"HS J\u00f8rgensen","year":"1996","unstructured":"J\u00f8rgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS. Acute stroke with atrial fibrillation. The Copenhagen Stroke Study. Stroke. 1996;27(10):1765\u20139.","journal-title":"Stroke."},{"issue":"10","key":"790_CR20","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1161\/hs1001.097093","volume":"32","author":"R Saxena","year":"2001","unstructured":"Saxena R, Lewis S, Berge E, Sandercock PA, Koudstaal PJ. Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. Stroke. 2001;32(10):2333\u20137.","journal-title":"Stroke."},{"issue":"2","key":"790_CR21","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1161\/01.STR.32.2.392","volume":"32","author":"M Lamassa","year":"2001","unstructured":"Lamassa M, Di Carlo A, Pracucci G, Basile AM, Trefoloni G, Vanni P, et al. Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project). Stroke. 2001;32(2):392\u20138.","journal-title":"Stroke."},{"key":"790_CR22","doi-asserted-by":"crossref","unstructured":"Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet. 1993;342(8882):1255\u201362.","DOI":"10.1016\/0140-6736(93)92358-Z"},{"issue":"6","key":"790_CR23","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S1474-4422(12)70092-3","volume":"11","author":"JD Easton","year":"2012","unstructured":"Easton JD, Lopes RD, Bahit MC, Wojdyla DM, Granger CB, Wallentin L, et al. Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial. Lancet Neurol. 2012;11(6):503\u201311.","journal-title":"Lancet Neurol"},{"issue":"12","key":"790_CR24","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S1474-4422(10)70274-X","volume":"9","author":"HC Diener","year":"2010","unstructured":"Diener HC, Connolly SJ, Ezekowitz MD, Wallentin L, Reilly PA, Yang S, et al. Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial. Lancet Neurol. 2010;9(12):1157\u201363.","journal-title":"Lancet Neurol"},{"issue":"4","key":"790_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S1474-4422(12)70042-X","volume":"11","author":"GJ Hankey","year":"2012","unstructured":"Hankey GJ, Patel MR, Stevens SR, Becker RC, Breithardt G, Carolei A, et al. Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol. 2012;11(4):315\u201322.","journal-title":"Lancet Neurol"},{"issue":"11","key":"790_CR26","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981\u201392.","journal-title":"N Engl J Med"},{"issue":"12","key":"790_CR27","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139\u201351.","journal-title":"N Engl J Med"},{"issue":"10","key":"790_CR28","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883\u201391.","journal-title":"N Engl J Med"},{"issue":"22","key":"790_CR29","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369(22):2093\u2013104.","journal-title":"N Engl J Med"},{"issue":"4","key":"790_CR30","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ahj.2010.06.042","volume":"160","author":"CT Ruff","year":"2010","unstructured":"Ruff CT, Giugliano RP, Antman EM, Crugnale SE, Bocanegra T, Mercuri M, et al. Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48). Am Heart J. 2010;160(4):635\u201341.","journal-title":"Am Heart J"},{"issue":"10","key":"790_CR31","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1161\/STROKEAHA.117.017084","volume":"48","author":"S Yaghi","year":"2017","unstructured":"\u2022\u2022 Yaghi S, Kamel H. Stratifying stroke risk in atrial fibrillation: beyond clinical risk scores. Stroke. 2017;48(10):2665\u201370 Excellent review on predictors of stroke risk in atrial fibrillation covering the recent data on left atrial cardiopathy, left atrial appendage morphology, and the burden of atrial fibrillation in relation to ischemic stroke risk.","journal-title":"Stroke"},{"issue":"20","key":"790_CR32","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/eurheartj\/ehw007","volume":"37","author":"AN Ganesan","year":"2016","unstructured":"Ganesan AN, Chew DP, Hartshorne T, Selvanayagam JB, Aylward PE, Sanders P, et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis. Eur Heart J. 2016;37(20):1591\u2013602.","journal-title":"Eur Heart J"},{"issue":"6","key":"790_CR33","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1161\/STROKEAHA.115.008711","volume":"46","author":"S Yaghi","year":"2015","unstructured":"Yaghi S, Moon YP, Mora-McLaughlin C, Willey JZ, Cheung K, Di Tullio MR, et al. Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study. Stroke. 2015;46(6):1488\u201393.","journal-title":"Stroke."},{"issue":"4","key":"790_CR34","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0002-9149(77)90064-9","volume":"40","author":"RC Hinton","year":"1977","unstructured":"Hinton RC, Kistler JP, Fallon JT, Friedlich AL, Fisher CM. Influence of etiology of atrial fibrillation on incidence of systemic embolism. Am J Cardiol. 1977;40(4):509\u201313.","journal-title":"Am J Cardiol"},{"issue":"4","key":"790_CR35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000118372","volume":"25","author":"S Micheli","year":"2008","unstructured":"Micheli S, Agnelli G, Caso V, Paciaroni M. Clinical benefit of early anticoagulation in cardioembolic stroke. Cerebrovasc Dis. 2008;25(4):289\u201396.","journal-title":"Cerebrovasc Dis"},{"key":"790_CR36","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Paciaroni M, Agnelli G, Falocci N, Tsivgoulis G, Vadikolias K, Liantinioti C, et al. Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with non-vitamin-K oral anticoagulants (RAF-NOACs) study. J Am Heart Assoc. 2017;6(12):e007034. \n                      https:\/\/doi.org\/10.1161\/JAHA.117.007034\n                      \n                    . Influential study on the relationship between anticoagulation and the risk of symptomatic hemorrhage in patients on NOACs.","DOI":"10.1161\/JAHA.117.007034"},{"issue":"3","key":"790_CR37","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1161\/STROKEAHA.116.015770","volume":"48","author":"M Paciaroni","year":"2017","unstructured":"Paciaroni M, Agnelli G, Caso V, Tsivgoulis G, Furie KL, Tadi P, et al. Prediction of early recurrent thromboembolic event and major bleeding in patients with acute stroke and atrial fibrillation by a risk stratification schema: the ALESSA score study. Stroke. 2017;48(3):726\u201332.","journal-title":"Stroke."},{"issue":"1","key":"790_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/jnnp-2016-314023","volume":"88","author":"S Yaghi","year":"2017","unstructured":"Yaghi S, Liberman AL, Atalay M, Song C, Furie KL, Kamel H, et al. Cardiac magnetic resonance imaging: a new tool to identify cardioaortic sources in ischaemic stroke. J Neurol Neurosurg Psychiatry. 2017;88(1):31\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9136","key":"790_CR39","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","volume":"352","author":"W Hacke","year":"1998","unstructured":"Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998;352(9136):1245\u201351.","journal-title":"Lancet"},{"issue":"9558","key":"790_CR40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0140-6736(07)60149-4","volume":"369","author":"N Wahlgren","year":"2007","unstructured":"Wahlgren N, Ahmed N, D\u00e1valos A, Ford GA, Grond M, Hacke W, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369(9558):275\u201382.","journal-title":"Lancet."},{"issue":"4","key":"790_CR41","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/ijs.12007","volume":"10","author":"HT Tu","year":"2015","unstructured":"Tu HT, Campbell BC, Christensen S, Desmond PM, De Silva DA, Parsons MW, et al. Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation. Int J Stroke. 2015;10(4):534\u201340.","journal-title":"Int J Stroke"},{"issue":"3","key":"790_CR42","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1055\/s-0037-1603465","volume":"37","author":"DC Sacchetti","year":"2017","unstructured":"Sacchetti DC, Furie KL, Yaghi S. Cardioembolic stroke: mechanisms and therapeutics. Semin Neurol. 2017;37(3):326\u201338.","journal-title":"Semin Neurol"},{"issue":"4","key":"790_CR43","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1161\/STROKEAHA.110.604652","volume":"42","author":"W Pfeilschifter","year":"2011","unstructured":"Pfeilschifter W, Spitzer D, Czech-Zechmeister B, Steinmetz H, Foerch C. Increased risk of hemorrhagic transformation in ischemic stroke occurring during warfarin anticoagulation: an experimental study in mice. Stroke. 2011;42(4):1116\u201321.","journal-title":"Stroke."},{"issue":"3","key":"790_CR44","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1385\/MN:28:3:229","volume":"28","author":"X Wang","year":"2003","unstructured":"Wang X, Lo EH. Triggers and mediators of hemorrhagic transformation in cerebral ischemia. Mol Neurobiol. 2003;28(3):229\u201344.","journal-title":"Mol Neurobiol"},{"key":"790_CR45","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jns.2016.11.065","volume":"372","author":"P Castro","year":"2017","unstructured":"Castro P, Azevedo E, Serrador J, Rocha I, Sorond F. Hemorrhagic transformation and cerebral edema in acute ischemic stroke: link to cerebral autoregulation. J Neurol Sci. 2017;372:256\u201361.","journal-title":"J Neurol Sci"},{"issue":"6","key":"790_CR46","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/ene.12126","volume":"20","author":"EB Marsh","year":"2013","unstructured":"Marsh EB, Llinas RH, Hillis AE, Gottesman RF. Hemorrhagic transformation in patients with acute ischaemic stroke and an indication for anticoagulation. Eur J Neurol. 2013;20(6):962\u20137.","journal-title":"Eur J Neurol"},{"issue":"5","key":"790_CR47","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1161\/STROKEAHA.113.004506","volume":"45","author":"GJ Hankey","year":"2014","unstructured":"Hankey GJ, Stevens SR, Piccini JP, Lokhnygina Y, Mahaffey KW, Halperin JL, et al. Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation. Stroke. 2014;45(5):1304\u201312.","journal-title":"Stroke."},{"issue":"3","key":"790_CR48","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1161\/01.STR.24.3.465","volume":"24","author":"CR Hornig","year":"1993","unstructured":"Hornig CR, Bauer T, Simon C, Trittmacher S, Dorndorf W. Hemorrhagic transformation in cardioembolic cerebral infarction. Stroke. 1993;24(3):465\u20138.","journal-title":"Stroke."},{"issue":"4","key":"790_CR49","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000319048","volume":"64","author":"JH Lee","year":"2010","unstructured":"Lee JH, Park KY, Shin JH, Cha JK, Kim HY, Kwon JH, et al. Symptomatic hemorrhagic transformation and its predictors in acute ischemic stroke with atrial fibrillation. Eur Neurol. 2010;64(4):193\u2013200.","journal-title":"Eur Neurol"},{"issue":"7","key":"790_CR50","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1161\/STROKEAHA.116.013491","volume":"47","author":"LC Gioia","year":"2016","unstructured":"Gioia LC, Kate M, Sivakumar L, Hussain D, Kalashyan H, Buck B, et al. Early rivaroxaban use after cardioembolic stroke may not result in hemorrhagic transformation: a prospective magnetic resonance imaging study. Stroke. 2016;47(7):1917\u20139.","journal-title":"Stroke."},{"issue":"6","key":"790_CR51","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1474-4422(13)70079-6","volume":"12","author":"WN Whiteley","year":"2013","unstructured":"Whiteley WN, Adams HP, Bath PM, Berge E, Sandset PM, Dennis M, et al. Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials. Lancet Neurol. 2013;12(6):539\u201345.","journal-title":"Lancet Neurol"},{"key":"790_CR52","doi-asserted-by":"publisher","unstructured":"Sandercock PA, Counsell C, Kane EJ. Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev. 2015;(3):CD000024. \n                      https:\/\/doi.org\/10.1002\/14651858.CD000024.pub4.","DOI":"10.1002\/14651858.CD000024.pub4."},{"issue":"2","key":"790_CR53","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1161\/01.STR.0000254600.92975.1f","volume":"38","author":"M Paciaroni","year":"2007","unstructured":"Paciaroni M, Agnelli G, Micheli S, Caso V. Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials. Stroke. 2007;38(2):423\u201330.","journal-title":"Stroke."},{"issue":"10","key":"790_CR54","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.07.006","volume":"23","author":"M Schrag","year":"2014","unstructured":"Schrag M, Greer DM. Clinical associations of cerebral microbleeds on magnetic resonance neuroimaging. J Stroke Cerebrovasc Dis. 2014;23(10):2489\u201397.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"6","key":"790_CR55","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1002\/mrm.22745","volume":"65","author":"G McAuley","year":"2011","unstructured":"McAuley G, Schrag M, Barnes S, Obenaus A, Dickson A, Holshouser B, et al. Iron quantification of microbleeds in postmortem brain. Magn Reson Med. 2011;65(6):1592\u2013601.","journal-title":"Magn Reson Med"},{"issue":"3","key":"790_CR56","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00401-009-0615-z","volume":"119","author":"M Schrag","year":"2010","unstructured":"Schrag M, McAuley G, Pomakian J, Jiffry A, Tung S, Mueller C, et al. Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol. 2010;119(3):291\u2013302.","journal-title":"Acta Neuropathol"},{"issue":"1\u20132","key":"790_CR57","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000452718","volume":"43","author":"A Malhotra","year":"2017","unstructured":"Malhotra A, Schindler J, Mac Grory B, Chu SY, Youn TS, Matouk C, et al. Cerebral microhemorrhages and meningeal siderosis in infective endocarditis. Cerebrovasc Dis. 2017;43(1\u20132):59\u201367.","journal-title":"Cerebrovasc Dis"},{"key":"790_CR58","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1212\/WNL.0000000000004704","volume":"89","author":"A Charidimou","year":"2017","unstructured":"\u2022 Charidimou A, Karayiannis C, Song TJ, Orken DN, Thijs V, Lemmens R, et al. Brain microbleeds, anticoagulation, and hemorrhage risk: meta-analysis in stroke patients with AF. Neurology. 2017. Comprehensive meta-analysis on the relationship between cerebral microhemorrhages and the risk of intracranial hemorrhage.;89:2317\u201326.","journal-title":"Neurology"},{"issue":"14","key":"790_CR59","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1212\/WNL.0000000000003183","volume":"87","author":"D Wilson","year":"2016","unstructured":"Wilson D, Charidimou A, Ambler G, Fox ZV, Gregoire S, Rayson P, et al. Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA: a meta-analysis. Neurology. 2016;87(14):1501\u201310.","journal-title":"Neurology."},{"issue":"5","key":"790_CR60","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/1747493016632239","volume":"11","author":"S Arihiro","year":"2016","unstructured":"Arihiro S, Todo K, Koga M, Furui E, Kinoshita N, Kimura K, et al. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: the SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study. Int J Stroke. 2016;11(5):565\u201374.","journal-title":"Int J Stroke"},{"issue":"18","key":"790_CR61","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1212\/WNL.0000000000003283","volume":"87","author":"DJ Seiffge","year":"2016","unstructured":"Seiffge DJ, Traenka C, Polymeris A, Hert L, Peters N, Lyrer P, et al. Early start of DOAC after ischemic stroke: risk of intracranial hemorrhage and recurrent events. Neurology. 2016;87(18):1856\u201362.","journal-title":"Neurology."},{"issue":"3","key":"790_CR62","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1136\/jnnp-2018-318890","volume":"90","author":"Duncan Wilson","year":"2018","unstructured":"Wilson D, Ambler G, Banerjee G, Shakeshaft C, Cohen H, Yousry TA, et al. Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study. Clinical relevance of Microbleeds in Stroke (CROMIS-2) collaborators. J Neurol Neurosurg Psychiatry. 2019;90(3):320\u2013325. \n                      https:\/\/doi.org\/10.1136\/jnnp-2018-318890","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"10","key":"790_CR63","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamaneurol.2017.2161","volume":"74","author":"KS Hong","year":"2017","unstructured":"Hong KS, Kwon SU, Lee SH, Lee JS, Kim YJ, Song TJ, et al. Rivaroxaban vs warfarin sodium in the ultra-early period after atrial fibrillation-related mild ischemic stroke: a randomized clinical trial. JAMA Neurol. 2017;74(10):1206\u201315.","journal-title":"JAMA Neurol"},{"issue":"7","key":"790_CR64","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1161\/STROKEAHA.118.021514","volume":"49","author":"AE Groot","year":"2018","unstructured":"Groot AE, Vermeij JM, Westendorp WF, Nederkoorn PJ, van de Beek D, Coutinho JM. Continuation or discontinuation of anticoagulation in the early phase after acute ischemic stroke. Stroke. 2018;49(7):1762\u20135.","journal-title":"Stroke."},{"issue":"9","key":"790_CR65","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.06.031","volume":"25","author":"K Macha","year":"2016","unstructured":"Macha K, Volbers B, Bobinger T, Kurka N, Breuer L, Huttner HB, et al. Early initiation of anticoagulation with direct oral anticoagulants in patients after transient ischemic attack or ischemic stroke. J Stroke Cerebrovasc Dis. 2016;25(9):2317\u201321.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"790_CR66","unstructured":"Optimal timing of anticoagulation after acute ischaemic stroke : a randomised controlled trial (OPTIMAS). \n                      https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03759938\n                      \n                    . Accessed 15 Jan 2019"},{"key":"790_CR67","unstructured":"Early versus late initiation of direct oral anticoagulants in post-ischaemic stroke patients with atrial fibrillation (ELAN): an international, multicentre, randomised-controlled, two-arm, assessor-blinded trial (ELAN). \n                      https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03148457\n                      \n                    . Accessed 15 Jan 2019"},{"key":"790_CR68","unstructured":"Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation. \n                      https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02961348\n                      \n                    . Accessed 15 Jan 2019"},{"key":"790_CR69","unstructured":"Optimal delay time to initiate anticoagulation after ischemic stroke in atrial fibrillation (START). \n                      https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03021928\n                      \n                    . Accessed 15 Jan 2019"},{"key":"790_CR70","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12883-014-0199-7","volume":"14","author":"F Palm","year":"2014","unstructured":"Palm F, Kraus M, Safer A, Wolf J, Becher H, Grau AJ. Management of oral anticoagulation after cardioembolic stroke and stroke survival data from a population based stroke registry (LuSSt). BMC Neurol. 2014;14:199.","journal-title":"BMC Neurol"},{"issue":"3","key":"790_CR71","first-page":"410","volume":"116","author":"M Paciaroni","year":"2016","unstructured":"Paciaroni M, Agnelli G, Ageno W, Caso V. Timing of anticoagulation therapy in patients with acute ischaemic stroke and atrial fibrillation. Thromb Haemost. 2016;116(3):410\u20136.","journal-title":"Thromb Haemost"},{"issue":"22","key":"790_CR72","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010133","volume":"7","author":"M Paciaroni","year":"2018","unstructured":"Paciaroni M, Bandini F, Agnelli G, Tsivgoulis G, Yaghi S, Furie KL, et al. Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: time to initiation of oral anticoagulant therapy and outcomes. J Am Heart Assoc. 2018;7(22):e010133.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"790_CR73","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/hr.2013.150","volume":"37","author":"K Toyoda","year":"2014","unstructured":"Toyoda K, Yasaka M, Uchiyama S, Iwade K, Koretsune Y, Nagata K, et al. CHADS2 and CHA2DS2-VASc scores as bleeding risk indices for patients with atrial fibrillation: the bleeding with antithrombotic therapy study. Hypertens Res. 2014;37(5):463\u20136.","journal-title":"Hypertens Res"},{"issue":"19","key":"790_CR74","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1136\/heartjnl-2013-305303","volume":"100","author":"LB Mitchell","year":"2014","unstructured":"Mitchell LB, Southern DA, Galbraith D, Ghali WA, Knudtson M, Wilton SB, et al. Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores. Heart. 2014;100(19):1524\u201330.","journal-title":"Heart."},{"issue":"6","key":"790_CR75","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1161\/01.STR.31.6.1240","volume":"31","author":"ZM Chen","year":"2000","unstructured":"Chen ZM, Sandercock P, Pan HC, Counsell C, Collins R, Liu LS, et al. Indications for early aspirin use in acute ischemic stroke : a combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. On behalf of the CAST and IST collaborative groups. Stroke. 2000;31(6):1240\u20139.","journal-title":"Stroke."},{"issue":"7","key":"790_CR76","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/ene.12577","volume":"22","author":"AH Abdul-Rahim","year":"2015","unstructured":"Abdul-Rahim AH, Fulton RL, Frank B, Tatlisumak T, Paciaroni M, Caso V, et al. Association of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy: analysis from VISTA. Eur J Neurol. 2015;22(7):1048\u201355.","journal-title":"Eur J Neurol"},{"key":"790_CR77","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.thromres.2016.06.014","volume":"144","author":"F AlKherayf","year":"2016","unstructured":"AlKherayf F, Xu Y, Gandara E, Westwick H, Moldovan ID, Wells PS. Timing of vitamin K antagonist re-initiation following intracranial hemorrhage in mechanical heart valves: systematic review and meta-analysis. Thromb Res. 2016;144:152\u20137.","journal-title":"Thromb Res"},{"issue":"1","key":"790_CR78","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5853\/jos.2016.00570","volume":"19","author":"MJ Lee","year":"2017","unstructured":"Lee MJ, Chung JW, Ahn MJ, Kim S, Seok JM, Jang HM, et al. Hypercoagulability and mortality of patients with stroke and active cancer: the OASIS-CANCER study. J Stroke. 2017;19(1):77\u201387.","journal-title":"J Stroke"},{"key":"790_CR79","doi-asserted-by":"publisher","unstructured":"Yaghi S, Pilot M, Song C, Blum CA, Yakhkind A, Silver B, et al. Ischemic stroke risk after acute coronary syndrome. J Am Heart Assoc. 2016;5(7). \n                      https:\/\/doi.org\/10.1161\/JAHA.115.002590","DOI":"10.1161\/JAHA.115.002590"},{"issue":"4","key":"790_CR80","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1161\/01.STR.28.4.762","volume":"28","author":"T Mooe","year":"1997","unstructured":"Mooe T, Eriksson P, Stegmayr B. Ischemic stroke after acute myocardial infarction. A population-based study. Stroke. 1997;28(4):762\u20137.","journal-title":"Stroke."},{"issue":"9689","key":"790_CR81","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","volume":"374","author":"DR Holmes","year":"2009","unstructured":"Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374(9689):534\u201342.","journal-title":"Lancet."},{"issue":"9","key":"790_CR82","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1001\/archneur.65.9.noc70105","volume":"65","author":"H Hallevi","year":"2008","unstructured":"Hallevi H, Albright KC, Martin-Schild S, Barreto AD, Savitz SI, Escobar MA, et al. Anticoagulation after cardioembolic stroke: to bridge or not to bridge? Arch Neurol. 2008;65(9):1169\u201373.","journal-title":"Arch Neurol"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-019-0790-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-019-0790-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-019-0790-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T23:48:29Z","timestamp":1589845709000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-019-0790-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,20]]},"references-count":82,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["790"],"URL":"https:\/\/doi.org\/10.1007\/s11883-019-0790-x","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,20]]},"assertion":[{"value":"20 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Brian Mac Grory, Shane Flood, Matthew Schrag, Maurizio Paciaroni, and Shadi Yaghi declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"29"}}